BIOMAT Database Logo BIOMAT Database Logo

Peritoneal Metastasis: Current Status and Treatment Options. 2021

Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Surgical Oncology Research Laboratory, Department of Surgery & Transplantation, University Hospital of Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.

Peritoneal metastasis (PM) originating from gastrointestinal cancer was considered a terminal disease until recently. The advent of better systemic treatment, a better understanding of prognostic factors, and finally, the advent of novel loco-regional therapies, has opened the door for the multimodal treatment of PM. These strategies, including radical surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) showed surprisingly good results, leading to the prolonged survival of patients with peritoneal metastasis. This has triggered a significant body of research, leading to the molecular characterization of PM, which may further help in the development of novel treatments. This review summarizes current evidence on peritoneal metastasis and explores potential novel mechanisms and therapeutic approaches to treat patients with peritoneal metastasis.

UI MeSH Term Description Entries

Related Publications

Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
[Current status of diagnosis and treatment of gastric cancer peritoneal metastasis].
March 2021, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options.
November 2019, International journal of molecular sciences,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
[Current surgical treatment options for liver metastasis].
January 2021, Therapeutische Umschau. Revue therapeutique,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Current treatment options for colon cancer peritoneal carcinomatosis.
September 2014, World journal of gastroenterology,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Spinal extradural metastasis: review of current treatment options.
January 2008, CA: a cancer journal for clinicians,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Peritoneal carcinomatosis with intraperitoneal immunotherapy: current treatment options and perspectives.
September 2022, Expert review of gastroenterology & hepatology,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Treatment of myelogenous leukemia: current status and investigational options.
April 1996, Blood,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Helicobacter pylori treatment in Turkey: Current status and rational treatment options.
January 2020, Northern clinics of Istanbul,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.
November 2019, Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association,
Lilian Roth, and Linda Russo, and Sima Ulugoel, and Rafael Freire Dos Santos, and Eva Breuer, and Anurag Gupta, and Kuno Lehmann
Treatment of Inherited Platelet Disorders: Current Status and Future Options.
August 2023, Hamostaseologie,
Copied contents to your clipboard!